{"id":"W4309028333","doi":"10.1200/jco.22.01000","title":"Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600–Mutant Low-Grade Glioma","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Brain Tumour Charity; Novartis Pharmaceuticals Corporation","keywords":"Trametinib; Dabrafenib; Medicine; Oncology; Dosing; Internal medicine; MEK inhibitor; Adverse effect; Pharmacology; Cancer; MAPK/ERK pathway; Kinase; Biology; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006403389,0.0003662694,0.0007967796,0.0002430439,0.000166143,0.0004529436,0.0002434593,0.0002463204,0.0007527479],"category_scores_gemma":[0.0006178045,0.0001694723,0.0005505717,0.0002902112,0.0003134057,0.0003924138,0.0001463159,0.001132058,0.0001893208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001025646,"about_ca_system_score_gemma":0.0009720641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001464884,"about_ca_topic_score_gemma":0.004731616,"domain_scores_codex":[0.9996921,0.0001203381,0.00002778343,0.00005133013,0.00006062698,0.00004785243],"domain_scores_gemma":[0.9996752,0.00005394791,0.0001257439,0.00002418909,0.00002489755,0.00009608582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1749391,0.01278523,0.09464946,0.001048294,0.001673386,0.0007000429,0.0003763595,0.01119299,0.1725226,0.0004338252,0.005274514,0.5244043],"study_design_scores_gemma":[0.05494142,0.5017845,0.3137061,0.0001981589,0.00239415,0.004799439,0.0003504281,0.01001575,0.09309817,0.0004259546,0.01817398,0.0001119774],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960598,0.002155466,0.0002668661,0.0001139438,0.00001646558,0.0001169551,0.0003576766,0.00002531958,0.0008873915],"genre_scores_gemma":[0.9970285,0.001384909,0.0006166587,0.00009235252,0.00002168747,0.00008619908,0.0005148648,0.000008438955,0.0002465599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001464884,"threshold_uncertainty_score":0.00744164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05730024859899788,"score_gpt":0.4027940956124643,"score_spread":0.3454938470134664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}